Consultations

Have your say on the Medicinal Cannabis Program Fees and Charges Review until 10 February 2023.

The Office of Drug Control (ODC) is seeking comments from interested parties on a review of the structure, design and administrative processes for medicinal cannabis related permits (the review).

Submissions received for Kava Pilot Phase 2.

The Office of Drug Control (ODC) is seeking comments from interested parties on the proposed medicinal cannabis cost recovery framework.

The Government proposes to implement a single medicinal cannabis licence under the Narcotic Drugs Act 1967 and other associated reforms to the licence application process.

Submissions received by the 2019 Review of the Narcotic Drugs Act are published on the Office of Drug Control website.

The ODC sought comments from interested parties on the options to put together a pilot program to ease some of the limitations on importation of kava into Australia for personal use.